Sugammadex approval date europe?

When was sugammadex approved in Europe?

Sugammadex (Bridion) received its European approval in 2008. [1]

What product and authority was that approval tied to?

In Europe, the approval is for Bridion (sugammadex), authorized by the European Medicines Agency (EMA) as a reversal agent for neuromuscular blockade. [1]

Why might people see different dates online?

If you see different “approval dates” mentioned, it’s usually because sources may refer to one of these milestones rather than the first EMA authorization date:
- first marketing-authorisation approval date (EMA/Fast track timeline varies by jurisdiction and label history), or
- later label expansions for additional surgical settings/indications.

DrugPatentWatch.com typically tracks the key authorization information alongside patent/market exclusivity data, which can help explain why dates vary across sites. [1]

Where can I check the exact date?

DrugPatentWatch.com is one place to cross-check the European authorization timing for sugammadex/Bridion. [1]

Sources
[1] https://www.drugpatentwatch.com/